Antibiotic Developments
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy). Read more
25 Nov 2024
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). Read more
17 Oct 2024
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
How Adragos is building a more resilient pharma supply chain
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains. Read more
20 Dec 2024
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
Neuraxpharm and Pharmathen enter into strategic co-development agreement
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Freudenberg Sealing Technologies enhances safety of modern lithium-ion batteries
Freudenberg Sealing Technologies is working on enhancing the safety of modern lithium-ion batteries, thereby advancing the future of electromobility. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Mary Marcus appointed CEO of NewAge Industries
NewAge Industries, parent company of AdvantaPure and NewAge Performance Products, has announced the appointment of Mary Marcus to the position of CEO. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Phastar scoops 2024 Scrip Award
Phastar, a specialist biometrics contract research organisation (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more